Literature DB >> 29623469

Role of ancillary techniques in profiling unclassified laryngeal malignancies.

H Hellquist1,2,3, J L Hunt4, A Cardesa5, A Skalova6, P J Slootweg7, A Rinaldo8, A Ferlito9.   

Abstract

Laryngeal biopsies, contrary to biopsies from many other sites of the body, very often contain minute amounts of tumour tissue that may consist of morphologically undifferentiated tumour only. In haematoxylin- and eosin-stained sections, there may be no indicative features of what specific tumour entity that is present. In the larynx, particularly small round cell neoplasms, primary or metastatic, often cause a diagnostic dilemma and where an incorrect diagnosis can induce substantial clinical consequences for the patient (e.g., primary neuroendocrine carcinomas vs metastatic variants, certain sarcomas). If sufficient/representative material has been obtained, the application of immunohistochemistry and/or molecular techniques should in virtually every case reveal the true nature of the malignancy. In cases with sparse amount of material, and therefore a limited number of sections to be cut, a careful and thoughtful stepwise approach is necessary to ascertain a reliable diagnosis, or at least guide the clinician to the most likely diagnoses. With today's advanced and widely available technology with an abundance of markers to discriminate different tumours, the use of the term "undifferentiated" should be largely unnecessary. In the exceptional, and indeed exceedingly rare cases, when a classification is not possible, even after repeat biopsy, we suggest that the laryngeal neoplasm is better termed "unclassified malignant neoplasm" rather than "undifferentiated malignant neoplasm".

Entities:  

Keywords:  FISH; Immunohistochemistry; Larynx; RT-PCR; Unclassified malignancies

Mesh:

Year:  2018        PMID: 29623469     DOI: 10.1007/s00428-018-2348-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  86 in total

1.  Liposarcoma of the larynx.

Authors:  Rosser Powitzky; Eric S Powitzky; Rafael Garcia
Journal:  Ann Otol Rhinol Laryngol       Date:  2007-06       Impact factor: 1.547

Review 2.  Primary primitive neuroectodermal tumor of the kidney. Case report and review of the literature.

Authors:  J Furman; W M Murphy; P F Jelsma; M G Garzotto; R D Marsh
Journal:  Am J Clin Pathol       Date:  1996-09       Impact factor: 2.493

3.  Rhabdomyosarcoma: a rare laryngeal neoplastic entity.

Authors:  B Pittore; G Fancello; P Cossu Rocca; G P Ledda; G Tore
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-02       Impact factor: 2.124

Review 4.  Dedifferentiated chondrosarcomas of the larynx: a report of two cases and review of the literature.

Authors:  Roberto E Garcia; Francis H Gannon; Lester D R Thompson
Journal:  Laryngoscope       Date:  2002-06       Impact factor: 3.325

5.  Primary Ewing sarcoma/primitive neuroectodermal tumor in the adrenal gland.

Authors:  Lian Zhang; Min Yao; Masanori Hisaoka; Hironobu Sasano; Hongwen Gao
Journal:  APMIS       Date:  2016-05-20       Impact factor: 3.205

6.  Laryngeal mucosal malignant melanoma. A clinicopathologic, immunohistochemical, and ultrastructural study of four patients and a review of the literature.

Authors:  B M Wenig
Journal:  Cancer       Date:  1995-04-01       Impact factor: 6.860

Review 7.  Adult laryngeal rhabdomyosarcoma: report of a case and literature review.

Authors:  A Shayah; F O Agada; L Karsai; N Stafford
Journal:  Ann Afr Med       Date:  2007-12

Review 8.  Primitive neuroectodermal tumor of the head and neck: incidence, diagnosis, and management.

Authors:  Jochen P Windfuhr
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-07       Impact factor: 1.547

9.  Chondrosarcoma of the larynx with additional malignant mesenchymal component (dedifferentiated chondrosarcoma).

Authors:  I J Bleiweiss; M Kaneko
Journal:  Am J Surg Pathol       Date:  1988-04       Impact factor: 6.394

10.  Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.

Authors:  Yin P Hung; Christopher D M Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2016-02-05       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.